Rosa
Payments companies reported to CMS as associated with Rosa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Rosa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Rosa
These are the largest totals companies reported as associated with Rosa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Atul Kamath | Manasquan, NJ | Adult Reconstructive Orthopaedic Surgery | $1,547,796.53 |
| David Miller | North Chesterfield, VA | Orthopaedic Surgery | $1,088,254.72 |
| Harlan Levine | Montvale, NJ | Orthopaedic Surgery | $1,070,147.89 |
| Henry Clarke | Phoenix, AZ | Orthopaedic Surgery | $1,034,469.15 |
| Christopher Cannova | Bethesda, MD | $1,030,868.73 | |
| Gregg Klein | Paramus, NJ | Orthopaedic Surgery | $1,015,722.70 |
| James Ballard | Oregon City, OR | Orthopaedic Surgery | $450,273.96 |
| Charles Lawrie | Miami, FL | Orthopaedic Surgery | $401,747.99 |
| Adolph Lombardi | New Albany, OH | Adult Reconstructive Orthopaedic Surgery | $399,246.86 |
| Thomas Tanous | Houston, TX | Orthopaedic Surgery | $387,949.29 |
Prescribed Rosa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.